Abstract:Chimeric antigen receptor T cell (CAR-T) therapy is a late-model of immune cell therapy that has been shown to be effective in refractory/recurrent B-cell leukemia and lymphoma. Compared with the traditional anti-tumor methods, CAR-T cell therapy has the advantages of higher specificity, stronger lethality and longer-lasting efficacy. Although CAR-T cells have made significant progress in the treatment of hematologic malignancies, diverse difficulties remain in the treatment of solid tumors, including immune escape due to tumor antigen heterogeneity, preventing entry or limiting the persistence of CAR-T cells by physical or cytokine barriers and along with other immunosuppressive molecule and cells in the tumor microenvironment (TME). Otherwise, the intracellular signaling of CAR also impact on CAR-T cells persistence. Appropriate modification of intracellular costimulatory molecular signal in the structure of CAR or coexpression of CAR and cytokines can provide a way to enhance CAR-T cells activity. Additionally, CAR-T cells dysfunction due to T cell exhaustion is associated with multi-factors, especially transcription factors, such as c-Jun, NR4A. Engineering CAR-T cells to coexpress or knockout transcription factors in favor of T<sub>CM</sub> memory CAR-T cells differentiation was proved to prolonged the survival of CAR-T cells. Finally, combination of CAR-T cells with oncolytic viruses, nanoparticles or immune checkpoint inhibitors provides an effective measure to improve CAR-T cells function. Here, we discuss all of these advances and challenges and review promising strategies for treating solid tumors. In particular, we also highlight that CAR-T cells have enormous potential to be used in combination with other immunotherapies.

The Brief Introduction Of CAR-T Cell Therapy in Cancer Tumors

CAR‐T Therapy in Clinical Practice: Technical Advances and Current Challenges

Persistence of both cords nine months post double cord blood transplantation for juvenile myelomonocytic leukaemia.

Current Clinical Application of the CAR-T Cell Therapy

Fine-Tuning through Generations: Advances in Structure and Production of CAR-T Therapy

Future Trends in CAR-T Cellular Immunotherapy and the Pros and Cons in Cancer Treatment

CAR‐T cell therapy: A breakthrough in traditional cancer treatment strategies (Review)

Toxicities and related improvements of CAR-T Cell in the treatment of cancer

Influencing factors and solution strategies of chimeric antigen receptor T-cell therapy (CAR-T) cell immunotherapy

Revolutionizing cancer treatment: an in-depth exploration of CAR-T cell therapies

Clinical Application and Risk Assessment of CAR-T Cell Technology in Cancer Immunotherapy

Improving the ability of CAR-T cells to hit solid tumors: Challenges and strategies

Clinical Investigations of CAR-T Cell Therapy for Solid Tumors

Bright future or blind alley? CAR-T cell therapy for solid tumors

CAR T-cell Therapy: A New Era in Cancer Immunotherapy

CAR T cell therapy: Current limitations and advancements in treating solid tumors

Evolving CAR-T-Cell Therapy for Cancer Treatment: From Scientific Discovery to Cures

A long way to the battlefront: CAR T cell therapy against solid cancers.

Advanced Strategies of CAR-T Cell Therapy in Solid Tumors and Hematological Malignancies

CAR-T in solid tumors: Blazing a new trail through the brambles

Current state of CAR-T therapy for T-cell malignancies